Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Singapore: A Vibrant Hub for Biomedical Scientists

Published: Friday, December 20, 2013
Last Updated: Friday, December 20, 2013
Bookmark and Share
Ng Siew Kiang, Executive Director for Contact Singapore, discusses the growth of the biomedical sector in Singapore.

Contact Singapore is an alliance of the Singapore Economic Development Board and Ministry of Manpower, which supports professionals and academics from across the globe seeking opportunities to work and live in Singapore. 

Recently, Singapore announced a novel discovery involving the use of nanodiamonds to boost the treatment of chemo-resistant leukaemia. The use of tiny diamonds to facilitate the delivery of drug to leukemic cells was developed by the National University of Singapore (NUS) in partnership with the University of California, Los Angeles (UCLA). In fact, such breakthroughs in areas from cancer and stem cell biology, cardiovascular diseases, diabetes, infectious diseases and neurosciences are commonplace in Singapore. Our research sector is a dynamic, fast-paced environment powered by a community of outstanding scientists and researchers. 

What makes Singapore stand out is our focus on forging collaboration between public and private sector research.  The Biopolis is a shiny beacon of this philosophy. Completed in 2006, this state-of-the-art research facility for biomedical and life sciences houses both public and corporate laboratories, offering unprecedented opportunities for collaboration and the integration of scientific capabilities that has propelled Singapore into a global biomedical sciences hub. 

Another example of knowledge-sharing and communication across different facets of industry is the Academia, an advanced facility which integrates pathology, medical education and research all under the same roof. The 13-storey twin-tower building which opened in July 2013 houses Singapore General Hospital’s pathology services, research laboratories, and education and training facilities of Singapore’s largest healthcare group, SingHealth. 

With such exciting investments come significant opportunities for researchers from all over the world to take up positions in Singapore. 

Singapore has long been at the forefront in supporting and promoting R&D efforts in Asia.  This is demonstrated not only by the calibre of public sector professionals and institutions based here, but also through the government’s active support of private sector research activity from corporate laboratories. 

Already, more than 50 global companies in Singapore are carrying out biomedical sciences R&D, which include drug discovery, translational and clinical research, supported by the government’s commitment to provide £8.3 billion of overall national funding across a range of research disciplines in its latest 5-year master plan ending in 2015.  

Over 6,000 researchers from across the globe currently live and work in Singapore. These companies and individuals have chosen Singapore for its reputation as a vibrant research environment, and because they recognise its potential to grow and develop further in years to come. Aside from a fast-growing research and academic environment, Singapore has a reputation for being one of the world’s most liveable cities, making it an ideal location for overseas professionals looking for a new challenge.

If you’d like to find out more about pursuing career opportunities in Singapore, please visit the link below for more information. 


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Cytoskeleton Crew
Findings confirm sugar's role in helping cancers survive by changing cellular architecture.
Biomarker for Recurring HPV-Linked Oropharyngeal Cancers
A look-back analysis of HPV infection antibodies in patients treated for oropharyngeal (mouth and throat) cancers linked to HPV infection suggests at least one of the antibodies could be useful in identifying those at risk for a recurrence of the cancer, say scientists at the Johns Hopkins University.
Valvena, GSK Sign New R&D Collaboration
Valneva to supply process development services for EB66® -based Influenza vaccines.
Light Signals from Living Cells
Fluorescent protein markers delivered under high pressure.
Cellular 'Relief Valve'
A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.
Genomic Signature Shared by Five Types of Cancer
National Institutes of Health researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer.
Cat Stem Cell Therapy Gives Humans Hope
By the time Bob the cat came to the UC Davis veterinary hospital, he had used up most of his nine lives.
Crowdfunding the Fight Against Cancer
From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
New Biomarker to Assess Stem Cells Developed
A research team led by scientists from UCL have found a way to assess the viability of 'manufactured' stem cells known as induced pluripotent stem cells (iPSCs). The team's discovery offers a new way to fast-track screening methods used in stem cell research.
A Better Model for Parkinson's
Scientists at EPFL solve a longstanding problem with modeling Parkinson’s disease in animals. Using newfound insights, they improve both cell and animal models for the disease, which can propel research and drug development.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!